Three more com­pa­nies price IPOs, bring­ing this year's raise up to $11.78B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

The biotech IPO rush con­tin­ues, as three more com­pa­nies — Nu­va­lent, Icosavax and Rally­bio — priced their pub­lic de­buts on Wednes­day and Thurs­day. So far, 92 com­pa­nies have priced or filed for IPOs this year, rais­ing a mas­sive $11.78 bil­lion and sur­pass­ing last year’s count of 91 pub­lic de­buts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.